Insulet

Insulet Corporation is a medical device company focused on developing and marketing insulin delivery systems for individuals with insulin-dependent diabetes. The company is best known for its Omnipod System, which includes a tubeless, self-adhesive disposable insulin infusion device that can be worn for up to three days, and a handheld wireless personal diabetes manager. This system is designed to provide a pain-free and automated experience for users managing their insulin needs. Founded in 2000 and headquartered in Acton, Massachusetts, Insulet primarily sells its products through independent distributors, pharmacy channels, and directly to patients in the United States, Canada, Europe, and the Middle East. Since receiving approval from the U.S. Food and Drug Administration in 2005, approximately 425,000 individuals worldwide have adopted the Omnipod System as part of their diabetes management regimen.

Luciana Borio

Board Member

Ana Maria Chadwick

CFO, Executive Vice President and Treasurer

Charles Liamos

COO

3 past transactions

Glooko

Series D in 2021
Glooko develops a remote patient-monitoring platform to identify at-risk patients with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to allow data capture and provide reports and analytics that aim to drive behavior change and outcomes. The platform not only syncs diabetes data but also enhances communication between individuals with diabetes and their healthcare providers, leading to improved health outcomes. Glooko is available on both Android and iOS, providing users with the ability to track their diabetes data on their smartphones.

Glooko

Series C in 2017
Glooko develops a remote patient-monitoring platform to identify at-risk patients with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to allow data capture and provide reports and analytics that aim to drive behavior change and outcomes. The platform not only syncs diabetes data but also enhances communication between individuals with diabetes and their healthcare providers, leading to improved health outcomes. Glooko is available on both Android and iOS, providing users with the ability to track their diabetes data on their smartphones.

Neighborhood Diabetes

Acquisition in 2011
Neighborhood Diabetes, Inc., a leading durable medical equipment distributor specializing in direct to consumer sales of diabetes supplies, including pharmaceuticals, and support services,
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.